Ulrich Kronthaler

Person

Marburg, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Factor VIII, von Willebrand factor or complexes thereof with prolon...
- Patent number 9,290,561
- Issue date Mar 22, 2016
- CSL Behring GmbH
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of VWF stabilized FVIII preparations and of VWF preparations wi...
- Patent number 9,107,902
- Issue date Aug 18, 2015
- CSL Behring GmbH
- Ulrich Kronthaler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified coagulation factor VIIa with extended half-life
- Patent number 8,765,915
- Issue date Jul 1, 2014
- CSL Behring GmbH
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Factor VIII, von willebrand factor or complexes thereof with prolon...
- Patent number 8,575,104
- Issue date Nov 5, 2013
- CSL Behring GmbH
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic application of Kazal-type serine protease inhibitors
- Patent number 8,283,319
- Issue date Oct 9, 2012
- CSL Behring GmbH
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE
- Publication number 20170080061
- Publication date Mar 23, 2017
- CSL BEHRING GMBH
- Thomas WEIMER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE
- Publication number 20140356346
- Publication date Dec 4, 2014
- CSL BEHRING GMBH
- Thomas WEIMER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FACTOR VIII, VON WILLEBRAND FACTOR OR COMPLEXES THEREOF WITH PROLON...
- Publication number 20140072561
- Publication date Mar 13, 2014
- CSL BEHRING GMBH
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALBUMIN FUSED COAGULATION FACTORS FOR NON-INTRAVENOUS ADMINISTRATIO...
- Publication number 20120148557
- Publication date Jun 14, 2012
- Ulrich Kronthaler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR THE PREVENTION AND TREATMENT OF CANCER BY INHIBITION OF...
- Publication number 20120039901
- Publication date Feb 16, 2012
- CSL Behring GmbH
- Ulrich Kronthaler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR VIII, VON WILLEBRAND FACTOR OR COMPLEXES THEREOF WITH PROLON...
- Publication number 20110183907
- Publication date Jul 28, 2011
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR THE PREVENTION AND TREATMENT OF CANCER BY INHIBITION OF...
- Publication number 20110044993
- Publication date Feb 24, 2011
- Ulrich Kronthaler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF VWF STABILIZED FVIII PREPARATIONS AND OF VWF PREPARATIONS WI...
- Publication number 20100286047
- Publication date Nov 11, 2010
- Ulrich Kronthaler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC APPLICATION OF KAZAL-TYPE SERINE PROTEASE INHIBITORS
- Publication number 20100279923
- Publication date Nov 4, 2010
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modified Coagulation Factor VIIa With Extended Half-Life
- Publication number 20090298760
- Publication date Dec 3, 2009
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Ulrich Kronthaler

Person

Patents Grantslast 30 patents

Factor VIII, von Willebrand factor or complexes thereof with prolon...

Use of VWF stabilized FVIII preparations and of VWF preparations wi...

Modified coagulation factor VIIa with extended half-life

Factor VIII, von willebrand factor or complexes thereof with prolon...

Therapeutic application of Kazal-type serine protease inhibitors

Patents Applicationslast 30 patents

MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE

MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE

FACTOR VIII, VON WILLEBRAND FACTOR OR COMPLEXES THEREOF WITH PROLON...

ALBUMIN FUSED COAGULATION FACTORS FOR NON-INTRAVENOUS ADMINISTRATIO...

METHOD FOR THE PREVENTION AND TREATMENT OF CANCER BY INHIBITION OF...

FACTOR VIII, VON WILLEBRAND FACTOR OR COMPLEXES THEREOF WITH PROLON...

METHOD FOR THE PREVENTION AND TREATMENT OF CANCER BY INHIBITION OF...

USE OF VWF STABILIZED FVIII PREPARATIONS AND OF VWF PREPARATIONS WI...

THERAPEUTIC APPLICATION OF KAZAL-TYPE SERINE PROTEASE INHIBITORS

Modified Coagulation Factor VIIa With Extended Half-Life